Published on in Vol 11 (2024)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/58499, first published
.

Journals
- Simoes-Gomes T, Potvin S, Giguère S, Beaudoin M, Phraxayavong K, Dumais A. Validation of an Upgraded Virtual Reality Platform Designed for Real-Time Dialogical Psychotherapies. BioMedInformatics 2025;5(1):4 View
- Milliken A, Collamore K, Ryan-Pettes S. Quality of life measures in treatment for active substance misuse: a scoping review. Quality of Life Research 2025;34(12):3407 View
- McCartney D, Irwin C, Arnold J, Gordon R, McLachlan A, McGregor I. Urinary Δ9-tetrahydrocannabinol and metabolite concentrations following cannabis use: A systematic review. Pharmacological Research 2026;225:108142 View
- Giguère S, Potvin S, Fortier A, Phraxayavong K, Lespérance F, Do A, Bahremand A, Dumais A. Virtual reality-based Avatar Therapy for treatment-resistant major depressive disorder: A pilot study. Psychiatry Research 2026;360:117080 View
- Dumais A, Giguère S, Nabalma S, Fortier A, Phraxayavong K, Potvin S. Individual Characteristics Associated with the Sense of Presence and Immersive Experience Appreciation in Virtual Reality. Psychology International 2026;8(3):51 View
- Fradette M, Azrak J, Nguyen M, Veillette F, Lanouette M, Wurtele Boudreau X, Thompson-Leclerc R, Senhaji M, Giguère S, Dumais A. Mécanismes thérapeutiques sous-jacents à l’intervention Avatar pour le traitement du trouble lié à l’usage de cannabis chez les patients atteints d’un trouble psychotique : une analyse de contenu. Santé mentale au Québec 2026;51(3):45 View
- Giguère S, Daianska A, Nabalma S, Veillette F, Phraxayavong K, Potvin S, Dumais A. Therapeutic Processes in Virtual Reality‐Based Avatar Therapy for Treatment‐Resistant Major Depressive Disorder: A Qualitative Analysis of Patients' Experiences. Clinical Psychology & Psychotherapy 2026;33(6) View
